San Francisco Sentry Investment Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$29K Hold
83
0.02% 434
2021
Q1
$23K Hold
83
0.01% 470
2020
Q4
$20K Hold
83
0.01% 462
2020
Q3
$24K Sell
83
-50
-38% -$13.9K 0.01% 412
2020
Q2
$35K Sell
133
-77
-37% -$23.1K 0.02% 366
2020
Q1
$67K Sell
210
-141
-40% -$42.8K 0.04% 257
2019
Q4
$104K Sell
351
-72
-17% -$20K 0.05% 280
2019
Q3
$98K Hold
423
0.04% 278
2019
Q2
$99K Buy
423
+26
+7% +$6K 0.05% 281
2019
Q1
$94K Buy
397
+11
+3% +$3.46K 0.04% 319
2018
Q4
$116K Sell
386
-80
-17% -$25.5K 0.05% 257
2018
Q3
$164K Buy
466
+80
+21% +$27.5K 0.06% 234
2018
Q2
$112K Buy
386
+70
+22% +$19.7K 0.05% 293
2018
Q1
$87K Buy
316
+206
+187% +$63.9K 0.03% 384
2017
Q4
$35K Hold
110
0.01% 488
2017
Q3
$35K Buy
110
+42
+62% +$12.4K 0.01% 477
2017
Q2
$19K Buy
+68
New +$18K 0.01% 466
2014
Q4
Sell
-51
Closed -$17K 186
2014
Q3
$17K Hold
51
0.01% 414
2014
Q2
$16K Hold
51
0.01% 431
2014
Q1
$16K Buy
+51
New +$16.2K 0.01% 468

Other funds holding BIIB

San Francisco Sentry Investment Group's BIIB Position: Q2 2021 in Review

San Francisco Sentry Investment Group held its Biogen (BIIB) position steady in Q2 2021 at 83 shares worth $29K. The position accounts for 0.02% of the portfolio, ranked #434.

San Francisco Sentry Investment Group first reported a position in BIIB in Q1 2014 and has held it in 20 quarters since. The position peaked at $164K in Q3 2018. 1,104 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • San Francisco Sentry Investment Group held 83 shares of Biogen worth $29K as of Q2 2021.
  • San Francisco Sentry Investment Group left its Biogen share count unchanged in Q2 2021.
  • Biogen made up 0.02% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #434 holding.
  • San Francisco Sentry Investment Group first reported a position in Biogen in Q1 2014 and has held it in 20 quarters since.
  • San Francisco Sentry Investment Group's Biogen position peaked at $164K in Q3 2018.
  • 1,104 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.